- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Hannover, Medizinische Hochschule Hannover, Dissertation, 2021
- Keyword
- Event
-
Veröffentlichung
- (where)
-
Hannover
- (who)
-
Bibliothek der Medizinischen Hochschule Hannover
- (when)
-
2021
- Creator
- Contributor
-
Saborowski, Michael
David, Sascha Igor
Vondran, Florian
Hannover Biomedical Research School
Klinik für Gastroenterologie, Hepatologie und Endokrinologie
- DOI
-
10.26068/mhhrpm/20211104-001
- URN
-
urn:nbn:de:101:1-2021111208034953418684
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:53 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Emamgholi, Fatemeh
- Saborowski, Michael
- David, Sascha Igor
- Vondran, Florian
- Hannover Biomedical Research School
- Klinik für Gastroenterologie, Hepatologie und Endokrinologie
- Bibliothek der Medizinischen Hochschule Hannover
Time of origin
- 2021
Other Objects (12)
Single center experience in pancreatic neuroendocrine tumors
Target identification and probe development for pancreatic neuroendocrine tumors
Molecularly targeted therapy on a new preclinical mouse model for gastric neuroendocrine tumors
Molecularly targeted therapy on a new preclinical mouse model for gastric neuroendocrine tumors
Opsoclonus-myoclonus syndrome associated with pancreatic neuroendocrine tumor: a case report
Metastasized pancreatic neuroendocrine tumor in a teenage girl: a case report
Orchestrating Treatment Modalities in Metastatic Pancreatic Neuroendocrine Tumors—Need for a Conductor
Metabolic Syndrome Is Associated with Impaired Survival after Surgery for Pancreatic Neuroendocrine Tumors
Dissecting the signalling network in pancreatic neuroendocrine neoplasms
Tumor growth rate as a metric of progression, response, and prognosis in pancreatic and intestinal neuroendocrine tumors
Pancreatic tumors
A Comprehensive Molecular Characterization of the Pancreatic Neuroendocrine Tumor Cell Lines BON-1 and QGP-1
Single center experience in pancreatic neuroendocrine tumors
Target identification and probe development for pancreatic neuroendocrine tumors
Molecularly targeted therapy on a new preclinical mouse model for gastric neuroendocrine tumors
Molecularly targeted therapy on a new preclinical mouse model for gastric neuroendocrine tumors
Opsoclonus-myoclonus syndrome associated with pancreatic neuroendocrine tumor: a case report
Metastasized pancreatic neuroendocrine tumor in a teenage girl: a case report
Orchestrating Treatment Modalities in Metastatic Pancreatic Neuroendocrine Tumors—Need for a Conductor
Metabolic Syndrome Is Associated with Impaired Survival after Surgery for Pancreatic Neuroendocrine Tumors
Dissecting the signalling network in pancreatic neuroendocrine neoplasms
Tumor growth rate as a metric of progression, response, and prognosis in pancreatic and intestinal neuroendocrine tumors
Pancreatic tumors
A Comprehensive Molecular Characterization of the Pancreatic Neuroendocrine Tumor Cell Lines BON-1 and QGP-1
Single center experience in pancreatic neuroendocrine tumors
Target identification and probe development for pancreatic neuroendocrine tumors
Molecularly targeted therapy on a new preclinical mouse model for gastric neuroendocrine tumors
Molecularly targeted therapy on a new preclinical mouse model for gastric neuroendocrine tumors
Opsoclonus-myoclonus syndrome associated with pancreatic neuroendocrine tumor: a case report
Metastasized pancreatic neuroendocrine tumor in a teenage girl: a case report
Orchestrating Treatment Modalities in Metastatic Pancreatic Neuroendocrine Tumors—Need for a Conductor
Metabolic Syndrome Is Associated with Impaired Survival after Surgery for Pancreatic Neuroendocrine Tumors
Dissecting the signalling network in pancreatic neuroendocrine neoplasms
Tumor growth rate as a metric of progression, response, and prognosis in pancreatic and intestinal neuroendocrine tumors
Pancreatic tumors